An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression

NCT00070694 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

NIH

Sponsor class

Conditions

Depressive Disorder

Interventions

DRUG: MDL100.907

Sponsor

National Institute of Mental Health (NIMH)